Prasugrel Treatment Patterns in Outpatient Settings in Germany, the United Kingdom, and France (H7T-MC-B011)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/20445
• EU PAS number:
  EUPAS5911
• Study ID:
  20445
• Official title and acronym:
  Prasugrel Treatment Patterns in Outpatient Settings in Germany, the United Kingdom, and France (H7T-MC-B011)
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany

  United Kingdom
• Study description:
  This study is a retrospective, nonintervention cohort study aimed at describing the treatment patterns of prasugrel in outpatient practices in Germany and France using the IMS Disease Analyzer and in the United Kingdom (UK) using the IMS Disease Analyzer and the Clinical Practice Research Datalink (CPRD), formerly known as General Practice Research Database (GPRD), starting from launch to 3 years postlaunch
• Study status:
  Finalised

Research institutions and networks

Institutions

IMS Health

Study timelines

Date when funding contract was signed

Planned: 23/03/2009

Actual: 23/03/2009

Study start date

Planned: 15/10/2009

Actual: 15/10/2009

Data analysis start date

Planned: 10/02/2013

Actual: 10/02/2013

Date of final study report

Planned: 09/04/2013

Actual: 09/04/2013

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Eli Lilly and Company and Daiichi Sankyo, Inc.

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)